-
To investigate whether gonadal hormones influence cognitive function in postmenopausal women, the authors administered a comprehensive battery of neuropsychological tests on two occasions (2 years apart) to participants enrolled in the population-based, longitudinal Melbourne Women's Midlife Health Project.
-
-
It might sound obvious to a reproductive medicine specialist to say that "every cell has a sex." On the other hand, even an obstetrician-gynecologist might be surprised to know how much of a contribution sex differences make to health and disease.
-
In this issue: New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
-
A number of previous reviews in OB/GYN Clinical Alert, including a Special Feature, have been devoted to preterm birth (PTB), a problem that has been on the rise in the United States despite significant efforts to curb it.
-
In this retrospective study of young women performed in New Zealand between 2005 and 2009, 57% of 452 patients with biopsy-proven cervical intraepithelial neoplasia (CIN) 2 were treated immediately whereas 157 (35%) met the criteria for conservative management.
-
Women who carry a deleterious germline mutation in BRCA1 or BRCA2 have a substantially higher lifetime risk of developing ovarian cancer.
-
In a retrospective chart review at a single university urogynecology practice between 2000 and 2009, the authors identified 197 patients who underwent posterior tibial nerve stimulation (PTNS) after failing medical therapy for overactive bladder (OAB) with anticholinergic medication.
-
The Cancer Genome Atlas research network (TCGA) is an open-sourced multi-institutional collaborative charged by the National Cancer Institute (NCI) and the National Human Genome Research Institute effort to explore the molecular aberrations of cancer to better understand the disease and identify new treatment approaches.
-
In the initial phase of data collection, the authors identified two vaginal cuff dehiscences out of 665 total laparoscopic hysterectomies with transvaginal cuff closure (0.3%).
